What Does an Abnormal Occult Blood Test Mean?

An abnormal (positive) occult blood test means that hidden blood has been detected in your stool, blood you likely cannot see with the naked eye. It does not mean you have cancer. In most cases, the blood comes from a non-cancerous source such as hemorrhoids, a stomach ulcer, or inflammation somewhere along the digestive tract. But because colorectal cancer and precancerous growths can also cause this kind of low-level bleeding, a positive result always warrants further investigation, typically a colonoscopy.

What the Test Is Actually Detecting

The word “occult” just means hidden. These tests look for traces of hemoglobin, the oxygen-carrying protein in red blood cells, mixed into your stool. The idea behind screening is straightforward: colorectal cancers and large precancerous polyps tend to bleed intermittently as stool passes over them. If you can catch that bleeding early, before symptoms appear, you have a much better chance of finding cancer at a treatable stage or removing a polyp before it turns cancerous at all.

There are two main types of stool-based occult blood tests. Guaiac-based tests (often called gFOBT) use a chemical reaction to detect the peroxidase activity of hemoglobin, but they are not specific to human blood and can react to certain foods or animal-derived hemoglobin. Fecal immunochemical tests (FIT) use antibodies that target human hemoglobin specifically, which means fewer dietary restrictions and generally better accuracy. FIT has largely replaced the older guaiac test in modern screening programs because it is more sensitive for cancers and advanced polyps, easier to use, and does not require you to avoid red meat or certain vegetables beforehand.¹

How Often a Positive Result Actually Means Cancer

This is the question that keeps people up at night after getting a callback from their doctor. The reassuring reality is that most positive occult blood tests do not turn out to be cancer. In one screening study of nearly 1,400 average-risk participants, colonoscopy after a positive FIT revealed cancer in about 0.7% of all screened individuals, advanced adenomas (large or worrisome polyps) in roughly 2%, and smaller non-advanced adenomas in about 1%.² The majority of people who tested positive had something benign, or nothing identifiable at all, causing the bleeding.

That said, polyps and early-stage cancers do bleed, and detecting them is the entire point. Cancers tend to bleed from erosions on their surface where stool rubs against the tumor. Polyps bleed by a different mechanism: the twisting and bending of the polyp as bowel contents move past can fracture delicate fronds and obstruct small blood vessels, leading to low-grade bleeding.³ Larger polyps have more blood supply and more surface area in contact with stool, which is why they tend to produce higher concentrations of hemoglobin and are more reliably detected by FIT.⁴

Common Non-Cancer Causes of a Positive Test

A wide range of conditions can put blood into your stool without any involvement of cancer or precancerous polyps. Hemorrhoids are probably the most common culprit. One large study found that people with hemorrhoids were nearly three times as likely to have a false-positive FIT result compared to people without them, even after accounting for other factors.⁵ Among people whose hemorrhoids were the only abnormal finding on colonoscopy, about 15% still tested positive.

Beyond hemorrhoids, common sources of occult blood include:

Peptic ulcers: Stomach or duodenal ulcers can bleed into the upper digestive tract, and that blood travels through the intestines and ends up in the stool.
Inflammatory bowel disease: Conditions like Crohn’s disease and ulcerative colitis cause chronic inflammation that can produce bleeding along the intestinal lining.
Diverticular disease: Small pouches in the colon wall can occasionally bleed.
Angiodysplasia: Fragile, abnormal blood vessels in the gut lining, more common in older adults, sometimes ooze small amounts of blood.

Upper gastrointestinal bleeding from ulcers is worth flagging specifically because some test types detect it better than others. In a study comparing three different fecal occult blood tests in patients with known upper GI bleeding from gastric and duodenal ulcers, a quantitative chemical test picked up bleeding in about 69% of cases, while an immunochemical test had a lower detection rate.⁶ This happens because hemoglobin from the stomach or duodenum gets partially digested as it passes through the intestines, making it harder for antibody-based FIT tests to recognize. If your doctor suspects an upper GI source of bleeding, other diagnostic approaches may be more appropriate than a standard FIT.

Medications and Diet That Can Affect Your Results

If you are taking blood thinners or anti-inflammatory drugs, you might wonder whether your medication caused a positive result rather than an actual problem in your gut. The answer here depends on which test you took and which study you ask.

One study found that the predictive value of fecal occult blood testing for advanced colon growths dropped substantially in people taking low-dose aspirin, NSAIDs, clopidogrel, or warfarin compared to people on no medications. In the control group, about 31% of positive tests pointed to advanced growths, versus roughly 20% or lower in the medicated groups.⁷ The logic makes sense: these drugs can cause small amounts of GI bleeding on their own, producing positive tests that have nothing to do with polyps or cancer.

However, a later systematic review and meta-analysis of FIT specifically found a different picture. When pooling data across multiple studies, the predictive accuracy of FIT for advanced growths was essentially the same in people taking oral anticoagulants or aspirin/NSAIDs as in people taking nothing. The authors concluded that stopping these medications before FIT screening is not necessary.⁸ The discrepancy likely reflects differences in the test types studied and the populations involved. In practice, most current guidelines do not ask you to stop medications before a FIT, but your doctor may want to know what you are taking when interpreting the result.

Diet matters more for the older guaiac-based tests. Because guaiac tests detect peroxidase activity rather than human hemoglobin specifically, they can produce false positives from red meat, broccoli, cauliflower, cantaloupe, and other foods with high peroxidase or chlorophyll content. FIT avoids this problem entirely since its antibodies only react to human hemoglobin.⁹

What Happens After a Positive Result

The standard next step after an abnormal occult blood test is a colonoscopy. This allows a gastroenterologist to visually inspect the entire colon, identify the source of bleeding, and remove any polyps found during the procedure. The colonoscopy is both diagnostic and, in many cases, therapeutic: if a precancerous polyp is found, it can be removed right then and there.

Timing matters. A large study following patients with positive FIT results found that getting a colonoscopy within about one to six months carried the lowest risk. When the colonoscopy was delayed to 10 to 12 months after the positive test, the risk of finding any colorectal cancer went up, along with the risk that cancer diagnosed would already be at an advanced stage. Waiting more than 12 months was associated with even higher risks of advanced-stage disease.¹⁰ A systematic review found a consistent pattern across studies: colonoscopy performed beyond nine months from a positive FIT was associated with roughly 1.5 to nearly 3 times the odds of being diagnosed with advanced-stage cancer compared to follow-up within a month.¹¹

The takeaway is that a positive test should not be ignored or indefinitely postponed. The window of a few months gives reasonable flexibility for scheduling, but stretching past nine months starts to erode the survival advantage that screening is supposed to provide.

Why Some People Skip the Follow-Up Colonoscopy

Despite clear recommendations, a substantial number of people with positive occult blood tests never complete the follow-up colonoscopy. A qualitative study exploring the reasons found several recurring themes: some patients and even their doctors assumed the positive result was a false positive, especially if the patient felt healthy. Others were simply afraid of the colonoscopy procedure. Some had competing health problems that seemed more urgent. And in a number of cases, the breakdown was logistical: results were not communicated clearly, or appointment scheduling fell through the cracks.¹²

One particularly risky pattern: some patients who dismissed the positive result as a false positive negotiated an alternative plan with their doctor, such as repeating the stool test instead of getting a colonoscopy. While repeating the test might seem reasonable, it can delay the diagnosis of a real problem. A negative repeat test does not rule out cancer or large polyps, because these growths bleed intermittently rather than continuously. A polyp that bled on Monday might not bleed on Thursday.

The Emotional Side of an Abnormal Result

Getting a positive occult blood test can be genuinely unsettling, even if your doctor reassures you that most results are benign. Research confirms this. In a study of people within an integrated healthcare system, those who received a positive result were almost four times as likely to report mood disturbance related to cancer worry in the first one to two weeks compared to people who tested negative. Their self-reported worry about colon cancer roughly doubled, and situational anxiety scores climbed meaningfully, though they did not reach clinically diagnosable levels.¹³

The good news is that the anxiety spike was short-lived. By four months after receiving the result, distress levels had returned close to baseline. If you are sitting with a positive result and feeling anxious, that reaction is normal and temporary, and it is not a reason to avoid the colonoscopy. Completing the follow-up tends to resolve the uncertainty that drives the worry, regardless of what the colonoscopy finds.

What the Test Can Miss

A negative occult blood test is not a guarantee that your colon is clear. These tests have real blind spots. FIT, the more accurate of the two main test types, is better at detecting growths in the lower (distal) part of the colon than in the upper (proximal) part. It also has a harder time catching flat or non-polypoid lesions and polyps smaller than about 15 millimeters. One study found that the odds of a false-negative FIT result were roughly three times higher for small adenomas and about twice as high for flat lesions compared to larger, protruding ones.¹⁴

This is why screening guidelines recommend repeating FIT annually or biennially rather than relying on a single test. A polyp that does not bleed during one sample collection may bleed during the next. Over multiple rounds, the cumulative chance of catching a significant growth improves dramatically. Stool DNA tests, which look for genetic mutations shed by tumors in addition to blood, offer higher sensitivity for cancer than FIT alone, though they are more expensive and used less widely in population screening.¹⁵

Why the Cut-Off Number on Your Lab Report Matters

If you look closely at your FIT result, you may see a number reported in micrograms of hemoglobin per gram of feces, along with a threshold that defines “positive.” That threshold varies depending on where you live. Different screening programs around the world use different cut-offs, and the choice has real consequences for what your test can and cannot detect.

At a low cut-off, the test catches more cancers and polyps but also flags more people for colonoscopy who turn out to have nothing wrong. At a high cut-off, fewer people get unnecessary colonoscopies, but more cancers slip through undetected. A large international analysis illustrated this starkly: at the lowest cut-off studied (about 8.5 micrograms per gram), roughly 98% of cancers were detected, but nearly 18% of all screened people tested positive, requiring enormous colonoscopy capacity. At the highest cut-off analyzed (120 micrograms per gram, used in parts of the United Kingdom), only about 56% of cancers were detected, but just 2.6% of people tested positive.¹⁶

A separate analysis found that moderate cut-offs around 9 to 25 micrograms per gram offered the steepest gains in predictive value, meaning fewer unnecessary colonoscopies per cancer found, before the returns started to flatten out.¹⁷ The practical implication for you: if your result is just barely above the cut-off, the chance it represents cancer is lower than if your hemoglobin level was many times the threshold. Your doctor may factor the actual number, not just the positive-or-negative label, into how urgently they recommend colonoscopy.

Does Screening With This Test Actually Save Lives?

The evidence that regular fecal occult blood screening reduces deaths from colorectal cancer is strong and comes from several large, long-running trials. A landmark trial published in the New England Journal of Medicine followed participants for 13 years and found that annual screening with guaiac-based fecal occult blood tests reduced colorectal cancer deaths by about a third compared to no screening, driven by catching cancers at an earlier stage.¹⁸ A French controlled study found a 16% reduction in colorectal cancer mortality in the overall screened population, rising to a 33% reduction among people who actually participated in at least one round of screening.¹⁹

A more recent Swedish study using routine population-based screening confirmed the general direction, finding a roughly 14% adjusted reduction in colorectal cancer mortality among those offered early screening.²⁰ These benefits hold up even with the older, less sensitive guaiac tests. Modern FIT is expected to do at least as well, though head-to-head long-term mortality trials comparing FIT directly to colonoscopy are still ongoing.

Special Situations That Affect Test Accuracy

Certain medical conditions can make the test harder to interpret. People with chronic kidney disease, for instance, tend to have higher rates of GI bleeding unrelated to cancer, due to the effects of uremia on blood vessel fragility and platelet function. A study of this population found that while the sensitivity of the immunochemical test went up in advanced kidney disease (it caught more true positives), the specificity dropped, meaning more false positives as well.²¹ For people in this situation, a positive test needs to be interpreted alongside the full clinical picture rather than triggering automatic alarm.

Similarly, if you have been recently diagnosed with an inflammatory bowel condition, a positive occult blood test is more likely reflecting active inflammation than an unsuspected cancer. Your gastroenterologist will already be monitoring your colon more directly in that case, usually with regular colonoscopies rather than stool-based screening.

Annual FIT Versus Other Screening Strategies

You might wonder whether a simple stool test done every year can really compete with a colonoscopy, which directly visualizes the entire colon. From a cost-effectiveness standpoint, annual or biennial FIT screening consistently performs well. The vast majority of studies that have compared FIT programs to colonoscopy every ten years found FIT to be either cost-saving or highly cost-effective.²² A 2024 modeling study estimated that under real-world adherence conditions, annual FIT yielded about 121 life-years gained per 1,000 people screened and was the most cost-effective strategy compared to newer blood-based tests.²³

The catch is adherence. FIT only works as a screening tool if you actually do it every year. A colonoscopy, by contrast, is a one-time event that covers you for roughly a decade if the results are normal. In populations where people reliably return for annual testing, FIT programs perform remarkably well. In populations where participation drops off after the first round, the cumulative benefit erodes quickly. So if you are the kind of person who will reliably do a stool test each year, FIT is an excellent and well-supported option. If you know you will forget or procrastinate, a colonoscopy may be the more reliable path to staying screened.